{"title":"The new face of HFpEF: systemic inflammation","authors":"Małgorzata Lelonek","doi":"10.5603/fc.96384","DOIUrl":null,"url":null,"abstract":"Systemic inflammation is proposed as background of development and progres of heart failure, especially in heart failure with preserved ejection fraction (HFpEF). High-sensitivity C-reactive protein seems to be an optimal biomarker of systemic inflammation. Knowledge of systemic inflammation is important for new therapeutic fields in HFpEF with potential in inhibition of IL-1β, IL-6 or galectin-3.","PeriodicalId":12308,"journal":{"name":"Folia Cardiologica","volume":"34 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Folia Cardiologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/fc.96384","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Systemic inflammation is proposed as background of development and progres of heart failure, especially in heart failure with preserved ejection fraction (HFpEF). High-sensitivity C-reactive protein seems to be an optimal biomarker of systemic inflammation. Knowledge of systemic inflammation is important for new therapeutic fields in HFpEF with potential in inhibition of IL-1β, IL-6 or galectin-3.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
